找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Genome Editing in Cardiovascular and Metabolic Diseases; Junjie Xiao Book 2023 The Editor(s) (if applicable) and The Author(s), under excl

[復(fù)制鏈接]
樓主: arouse
31#
發(fā)表于 2025-3-27 00:52:05 | 只看該作者
32#
發(fā)表于 2025-3-27 02:38:11 | 只看該作者
33#
發(fā)表于 2025-3-27 05:22:00 | 只看該作者
https://doi.org/10.1007/978-981-10-6563-7ble to perform these types of experiments. Here, the different strategies for gene editing and their online tools are gathered, putting the light on its application in the study and treatment of cardiovascular and metabolic diseases.
34#
發(fā)表于 2025-3-27 10:41:09 | 只看該作者
Online Databases of Genome Editing in Cardiovascular and Metabolic Diseasesble to perform these types of experiments. Here, the different strategies for gene editing and their online tools are gathered, putting the light on its application in the study and treatment of cardiovascular and metabolic diseases.
35#
發(fā)表于 2025-3-27 17:08:51 | 只看該作者
Book 2023dology of genome editing. Genome editing is a genetic engineering technique precisely modified specific target genes of organism genome, which has been applied to basic theoretical research and production applications from plants and animals to gene therapy of human beings. Cardiovascular and metabo
36#
發(fā)表于 2025-3-27 19:30:59 | 只看該作者
37#
發(fā)表于 2025-3-28 00:38:52 | 只看該作者
38#
發(fā)表于 2025-3-28 02:17:55 | 只看該作者
E. Galán,R. Ca?ada,F. Fernández,B. Cerverasafety issues related to the once-and-done therapy focusing on CRISPR/Cas systems. We give an outlook on the potential gene targets prioritized by large-scale genetic studies of cardiovascular diseases and genome editing in precision medicine of dyslipidemia and atherosclerosis.
39#
發(fā)表于 2025-3-28 09:31:44 | 只看該作者
40#
發(fā)表于 2025-3-28 12:49:09 | 只看該作者
Genome Editing and Myocardial Developmentmodels are well-suited to study and predict clinical outcome. This review summarizes the anatomical and genetic timeline of myocardial development in both mice and humans, the potential of gene editing in typical CHD categories, as well as the use of mice thus far in reproducing models of human CHD and correcting the mutations that create them.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 20:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
胶州市| 社会| 萍乡市| 儋州市| 富裕县| 尖扎县| 岢岚县| 湘阴县| 师宗县| 南城县| 新丰县| 德庆县| 喜德县| 湛江市| 青铜峡市| 锡林浩特市| 吉安县| 竹溪县| 威海市| 如东县| 寻甸| 腾冲县| 东乡县| 喀喇| 呈贡县| 亳州市| 托克托县| 西藏| 监利县| 兴业县| 阳新县| 遵义市| 太仓市| 永年县| 湛江市| 定陶县| 区。| 肇州县| 治多县| 金塔县| 肇源县|